Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Todd M. Sanger, PhD
JCP
Original Research
A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder
February 15, 2007
Michael E. Thase
,
Sara A. Corya
,
Olawale Osuntokun
, et al
JCP
Original Research
Olanzapine/Fluoxetine Combination for Treatment-Resistant Depression: A Controlled Study of SSRI and Nortriptyline Resistance
October 14, 2005
Richard C. Shelton
,
Douglas J. Williamson
,
Sara A. Corya
, et al
JCP
Original Research
Long-Term Antidepressant Efficacy and Safety of Olanzapine/Fluoxetine Combination: A 76-Week Open-Label Study
November 15, 2003
Sara A. Corya
,
Scott W. Andersen
,
Holland C. Detke
, et al
JCP
Original Research
Long-Term Olanzapine Therapy in the Treatment of Bipolar I Disorder: An Open-Label Continuation Phase Study
April 1, 2001
Todd M. Sanger
,
Starr L. Grundy
,
P. Joseph Gibson
, et al
